FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pranatharthi Chandrasekar

Research Profile

Chemicals & Drugs

Procedures

Disorders

Living Beings

Concepts & Ideas

Treatment Outcome

Physiology

Co-author Network

Publications

TOP 3
Chin Y Liu; Ashiq Masood; Pranatharthi H Chandrasekar; Charles A Schiffer
Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
S Krishnan Natesan; Wenjuan Wu; J L Cutright; Pranatharthi H Chandrasekar
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Kayoko Hayakawa; Balaji Ramasamy; Pranatharthi H Chandrasekar
Fever of unknown origin: an evidence-based review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pranatharthi Chandrasekar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Chin Y Liu; Ashiq Masood; Pranatharthi H Chandrasekar; Charles A Schiffer
Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2013;19(1):18-23.
2012: S Krishnan Natesan; Wenjuan Wu; J L Cutright; Pranatharthi H Chandrasekar
In vitro-in vivo correlation of voriconazole resistance due to G448S mutation (cyp51A gene) in Aspergillus fumigatus.
Diagnostic microbiology and infectious disease 2012;74(3):272-7.
2012: Kayoko Hayakawa; Balaji Ramasamy; Pranatharthi H Chandrasekar
Fever of unknown origin: an evidence-based review.
The American journal of the medical sciences 2012;344(4):307-16.
2012: M Miceli; S Cronin; George J Alangaden; Lois Jeanne Ayash; Pranatharthi H Chandrasekar
Significant interaction of tacrolimus with ritonavir during allogeneic hematopoietic SCT in an HIV-infected patient.
Bone marrow transplantation 2012;47(8):1140-2.
2012: Suganthini Krishnan-Natesan; Wenjuan Wu; Pranatharthi H Chandrasekar
In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
Diagnostic microbiology and infectious disease 2012;73(2):135-7.
2012: R Bharadwaj; Marilynn R Fairfax; A Frey; Hossein Salimnia; S Swaminathan; Pranatharthi H Chandrasekar
Clinical impact of the use of 16S rRNA sequencing method for the identification of "difficult-to-identify" bacteria in immunocompromised hosts.
Transplant infectious disease : an official journal of the Transplantation Society 2012;14(2):206-12.
2012: Marisa H Miceli; Pranatharthi H Chandrasekar
Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.
Infection and drug resistance 2012;5():9-16.
2012: Christos I Kosmidis; Pranatharthi H Chandrasekar
Management of gram-positive bacterial infections in patients with cancer.
Leukemia & lymphoma 2012;53(1):8-18.
2011: Pranatharthi H Chandrasekar
Urgent need for formal medical training in infectious diseases in India.
The Lancet infectious diseases 2011;11(11):809-10.
2011: Hossein Salimnia; George J Alangaden; R Bharadwaj; T M Painter; Pranatharthi H Chandrasekar; Marilynn R Fairfax
Weissella confusa: an unexpected cause of vancomycin-resistant gram-positive bacteremia in immunocompromised hosts.
Transplant infectious disease : an official journal of the Transplantation Society 2011;13(3):294-8.
2011: Pranatharthi H Chandrasekar
Management of invasive fungal infections: a role for polyenes.
The Journal of antimicrobial chemotherapy 2011;66(3):457-65.
2011: Teena Chopra; Pranatharthi H Chandrasekar; Hossein Salimnia; Lance K Heilbrun; Daryn Smith; George J Alangaden
Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.
Clinical transplantation 2011;25(1):E82-7.
2010: Hossein Salimnia; D Patel; P R Lephart; Marilynn R Fairfax; Pranatharthi H Chandrasekar
Listeria grayi: vancomycin-resistant, gram-positive rod causing bacteremia in a stem cell transplant recipient.
Transplant infectious disease : an official journal of the Transplantation Society 2010;12(6):526-8.
2010: Tejal Mehta; Eric McGrath; Suchitha Bheemreddy; Hossein Salimnia; Nahed M Abdel-Haq; Jocelyn Y Ang; Lawrence George Lum; Pranatharthi H Chandrasekar; George J Alangaden
Detection of oseltamivir resistance during treatment of 2009 H1N1 influenza virus infection in immunocompromised patients: utility of cycle threshold values of qualitative real-time reverse transcriptase PCR.
Journal of clinical microbiology 2010;48(11):4326-8.
2010: Teena Chopra; George J Alangaden; Pranatharthi H Chandrasekar
Clostridium difficile infection in cancer patients and hematopoietic stem cell transplant recipients.
Expert review of anti-infective therapy 2010;8(10):1113-9.
2010: George J Alangaden; Pranatharthi H Chandrasekar
Case 10-2010: a woman with weakness and a mass in the brain.
The New England journal of medicine 2010;363(4):395; author reply 395-6.
2010: Amar Safdar; Jonathan Ma; Fouzi Saliba; Bertrand Dupont; John R Wingard; Ray Y Hachem; Gloria N Mattiuzzi; Pranatharthi H Chandrasekar; Dimitrios P Kontoyiannis; Kenneth V Rolston; THOMAS WALSH; Richard E Champlin; Issam I Raad
Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis.
Medicine 2010;89(4):236-44.
2010: Suganthini Krishnan-Natesan; Elias K Manavathu; Jessica L Cutright; Pranatharthi H Chandrasekar
Efficacy of anidulafungin, caspofungin and fluconazole in the early phase of infection in a neutropenic murine invasive candidiasis model.
International journal of antimicrobial agents 2010;36(1):33-6.
2010: S Narreddy; Elias K Manavathu; Pranatharthi H Chandrasekar; George J Alangaden; Sanjay G Revankar
In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes.
The Journal of antimicrobial chemotherapy 2010;65(4):701-3.
2010: Pranatharthi H Chandrasekar
Diagnostic challenges and recent advances in the early management of invasive fungal infections.
European journal of haematology 2010;84(4):281-90.
2010: Krista Wahby; Teena Chopra; Pranatharthi H Chandrasekar
Intravenous and inhalational colistin-induced respiratory failure.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(6):e38-40.
2010: Simon Cronin; Pranatharthi H Chandrasekar
Safety of triazole antifungal drugs in patients with cancer.
The Journal of antimicrobial chemotherapy 2010;65(3):410-6.
2009: Pranatharthi H Chandrasekar; Mayur Ramesh
Challenges in the management of invasive aspergillosis in hematopoietic stem cell transplantation.
Expert review of anti-infective therapy 2009;7(10):1151-3.
2009: Michael D Nailor; Pranatharthi H Chandrasekar
Antifungal drugs: predicting clinical efficacy with pharmacodynamics.
Expert review of clinical pharmacology 2009;2(4):373-9.
2009: Pranatharthi H Chandrasekar
Invasive mold infections: recent advances in management approaches.
Leukemia & lymphoma 2009;50(5):703-15.
2009: Suganthini Krishnan; Elias K Manavathu; Pranatharthi H Chandrasekar
Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance.
Mycoses 2009;52(3):206-22.
2009: Suganthini Krishnan-Natesan; Elias K Manavathu; George J Alangaden; Pranatharthi H Chandrasekar
A comparison of the fungicidal activity of amphotericin B and posaconazole against Zygomycetes in vitro.
Diagnostic microbiology and infectious disease 2009;63(4):361-4.
2009: Pranatharthi H Chandrasekar
Prophylaxis against Aspergillus is not perfect: problems and perils in stem cell transplantation.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47 Suppl 1():S349-54.
2008: Pranatharthi H Chandrasekar
Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate.
Therapeutics and clinical risk management 2008;4(6):1285-94.
2008: Suganthini Krishnan-Natesan; Pranatharthi H Chandrasekar; Elias K Manavathu; Sanjay G Revankar
Successful treatment of primary cutaneous Aspergillus ustus infection with surgical debridement and a combination of voriconazole and terbinafine.
Diagnostic microbiology and infectious disease 2008;62(4):443-6.
2008: Suganthini Krishnan-Natesan; Pranatharthi H Chandrasekar; George J Alangaden; Elias K Manavathu
Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus.
International journal of antimicrobial agents 2008;32(6):519-24.
2008: Mayur Ramesh; Pranatharthi H Chandrasekar
Effective alternates to trimethoprim-sulfamethoxazole as antimicrobial prophylaxis in stem cell recipients: are there any?
Pediatric transplantation 2008;12(8):823-6.
2008: Scott A Gruber; Mona Doshi; Elizabeth Cincotta; Kristian L Brown; Atul Singh; Katherina Morawski; George J Alangaden; Pranatharthi H Chandrasekar; Julian E Losanoff; Miguel Samuel West; Jose M El-Amm
Preliminary experience with renal transplantation in HIV+ recipients: low acute rejection and infection rates.
Transplantation 2008;86(2):269-74.
2008: Pranatharthi H Chandrasekar; Per T Ljungman
Antifungal therapy strategies in hematopoietic stem-cell transplant recipients: early treatment options for improving outcomes.
Transplantation 2008;86(2):183-91.
2008: Suganthini Krishnan Natesan; Pranatharthi H Chandrasekar; George J Alangaden; Elias K Manavathu
Fluvastatin potentiates the activity of caspofungin against Aspergillus fumigatus in vitro.
Diagnostic microbiology and infectious disease 2008;60(4):369-73.
2008: Pranatharthi H Chandrasekar; Elias K Manavathu
Do Aspergillus species produce biofilm?
Future microbiology 2008;3(1):19-21.
2008: S M Cronin; Muneer H Abidi; C J Shearer; Pranatharthi H Chandrasekar; Rami B Ibrahim
Rhodococcus equi lung infection in an allogeneic hematopoietic stem cell transplant recipient.
Transplant infectious disease : an official journal of the Transplantation Society 2008;10(1):48-51.
2008: Suganthini Krishnan-Natesan; Pranatharthi H Chandrasekar
Current and future therapeutic options in the management of invasive aspergillosis.
Drugs 2008;68(3):265-82.
2008: Suneetha Narreddy; Pranatharthi H Chandrasekar
False-positive Aspergillus galactomannan (GM) assay in histoplasmosis.
The Journal of infection 2008;56(1):80-1.
2007: Gopal Krishna; Monika Martinho; Pranatharthi H Chandrasekar; Andrew J Ullmann; Hernando Patino
Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.
Pharmacotherapy 2007;27(12):1627-36.
2007: Abdolreza Haririan; Katherina Morawski; Miguel Samuel West; Jose M El-Amm; Mona Doshi; Elizabeth Cincotta; George J Alangaden; Pranatharthi H Chandrasekar; Scott A Gruber
Sirolimus exposure during the early post-transplant period reduces the risk of CMV infection relative to tacrolimus in renal allograft recipients.
Clinical transplantation 2007;21(4):466-71.
2007: S Narreddy; S Mellon-Reppen; Muneer H Abidi; Jared L Klein; Edward M Peres; Lance K Heilbrun; D Smith; George J Alangaden; Pranatharthi H Chandrasekar
Non-bacterial infections in allogeneic non-myeloablative stem cell transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2007;9(1):3-10.
2007: Nelia M Afonso; Sunethra Gunasena; Karuna Galla; Raymond P Podzorski; Pranatharthi H Chandrasekar; George J Alangaden
Appropriate use of polymerase chain reaction for detection of herpes simplex virus 2 in cerebrospinal fluid of patients at an inner-city hospital.
Diagnostic microbiology and infectious disease 2007;57(3):309-13.
2007: Pranatharthi H Chandrasekar
Increased dose of echinocandins for invasive fungal infections: bonanza for the patient or the pharmaceutical industry?
Bone marrow transplantation 2007;39(3):129-31.
2007: Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi H Chandrasekar; Amelia Langston; stefano r tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
The New England journal of medicine 2007;356(4):335-47.
2007: THOMAS WALSH; Issam Raad; Thomas Patterson; Pranatharthi H Chandrasekar; Gerald R Donowitz; Richard Graybill; Reginald E Greene; Ray Hachem; Susan Hadley; Raoul Herbrecht; Amelia Langston; Arnold Louie; Patricia Ribaud; Brahm H Segal; David A Stevens; Jo-Anne H van Burik; Charles S White; Gavin Corcoran; Jagadish Gogate; Gopal Krishna; Lisa Pedicone; Catherine J Hardalo; John R Perfect
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):2-12.
2006: Elias J Anaissie; Brahm H Segal; John Graybill; Carola Arndt; John R Perfect; Michael E Kleinberg; Peter Pappas; Danny Benjamin; Robert Rubin; Judith A Aberg; Elisabeth E Adderson; Felice C Adler-Shohet; Hamdi Akan; Murat Akova; Nikolaos G Almyroudis; Barbara D Alexander; David Andes; Antonio Arrieta; John W Baddley; Michelle A Barron; Howard Belzberg; Helen W Boucher; Thomas G Boyce; Arturo Casadevall; Pranatharthi H Chandrasekar; John D Cleary; Catherine Cordonnier; Oliver A Cornely; Manuel Cuenca-Estrella; Jennifer S Daly; Nicholas Daoura; David W Denning; Ben dePauw; Louis de Repentigny; Maria Cecilia Dignani; William E Dismukes; J Peter Donnelly; Gerald R Donowitz; Bertrand Dupont; George L Drusano; Michael Ellis; Ana Espinel-Ingroff; Jay A Fishman; Rhonda Fleming; Graeme Forrest; Mahmoud Ghannoum; Mitchell Goldman; Monica Grazziutti; John N Greene; Richard N Greenberg; Paul O Gubbins; Susan Hadley; Raoul Herbrecht; John W Hiemenz; William Hope; Durane R Hospenthal; Shahid Husain; James I Ito; Robert M Jacobson; Melissa Johnson; Michael R Keating; Daniel H Kett; Katherine Knapp; Dimitrios P Kontoyiannis; Vladimir C Krcmery; Robert Larsen; Michel Laverdiere; Per Ljungman; O Lortholary; Johan Maertens; Debbie Marriott; Gloria Mattiuzzi; Michael R McGinnis; Michele Morris; Marcio Nucci; Frank C Odds; George A Pankey; Thomas Patterson; Mike Pfaller; Raymond R Razonable; Annette C Reboli; Michael G Rinaldi; Glenn D Roberts; Juan Luis Rodriguez Tudela; Coleman Rotstein; Markus Ruhnke; Mindy Schuster; Shmuel Shoham; Irene G Sia; Nita Siebel; Fernanda Silviera; Nina Singh; Jack D Sobel; Joseph S Solomkin; Tania C Sorrell; William J Steinbach; Zelalem Temesgen; AnnaMaria Tortorano; Shahe Vartivarian; Paul VerWeij; Claudio Viscoli; Maria Anna Viviani; Randall C Walker; Joseph L Wheat; Joseph Wiley; Peter R Williamson; John R Wingard; Victor L Yu; Theoklis Zaoutis
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(8):1031-9.
2006: George J Alangaden; Rama Thyagarajan; Scott A Gruber; Katherina Morawski; James Garnick; Jose M El-Amm; Miguel Samuel West; Dale H Sillix; Pranatharthi H Chandrasekar; Abdolreza Haririan
Infectious complications after kidney transplantation: current epidemiology and associated risk factors.
Clinical transplantation 2006;20(4):401-9.
2006: Pranatharthi H Chandrasekar
The experience is CLEAR.
International journal of antimicrobial agents 2006;27 Suppl 1():31-5.
2006: Pranatharthi H Chandrasekar
Selection criteria for antifungals: the right patients and the right reasons.
International journal of antimicrobial agents 2006;27 Suppl 1():17-20.
2006: Pranatharthi H Chandrasekar; Jack D Sobel
Micafungin: a new echinocandin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(8):1171-8.
2005: James I Ito; Pranatharthi H Chandrasekar; Roya Hooshmand-Rad
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
Bone marrow transplantation 2005;36(10):873-7.
2005: Suganthini Krishnan; Elias K Manavathu; Pranatharthi H Chandrasekar
A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
The Journal of antimicrobial chemotherapy 2005;55(6):914-20.
2005: Pranatharthi H Chandrasekar
Antifungal resistance in Aspergillus.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S295-8.
2005: Pranatharthi H Chandrasekar; James I Ito
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40 Suppl 6():S392-400.
2005: Scott A Gruber; James Garnick; Katherina Morawski; Dale H Sillix; Miguel Samuel West; Darla K Granger; Jose M El-Amm; George J Alangaden; Pranatharthi H Chandrasekar; Abdolreza Haririan
Cytomegalovirus prophylaxis with valganciclovir in African-American renal allograft recipients based on donor/recipient serostatus.
Clinical transplantation 2005;19(2):273-8.
2005: Pranatharthi H Chandrasekar
Riches usher dilemmas: antifungal therapy in invasive aspergillosis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):77-84.
2005: Elias K Manavathu; Jessica L Cutright; Pranatharthi H Chandrasekar
In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Antimicrobial agents and chemotherapy 2005;49(1):428-30.
2005: Pranatharthi H Chandrasekar
Real-time polymerase chain reaction for early diagnosis of toxoplasmosis in stem cell transplant recipients: ready for prime time?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(1):79-81.
2004: Hani M Wadei; George J Alangaden; Dale H Sillix; Jose M El-Amm; Scott A Gruber; Miguel Samuel West; Darla K Granger; James Garnick; Pranatharthi H Chandrasekar; Stephen D Migdal; Abdolreza Haririan
West Nile virus encephalitis: an emerging disease in renal transplant recipients.
Clinical transplantation 2004;18(6):753-8.
2004: Latha T Ganesan; Elias K Manavathu; Jessica L Cutright; George J Alangaden; Pranatharthi H Chandrasekar
In-vitro activity of nikkomycin Z alone and in combination with polyenes, triazoles or echinocandins against Aspergillus fumigatus.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(11):961-6.
2004: Pranatharthi H Chandrasekar; Jessica L Cutright; Elias K Manavathu
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(10):925-8.
2004: Priya Vishnubhotla; Rami B Ibrahim; Muneer H Abidi; Pranatharthi H Chandrasekar
Fever and eosinophilia associated with voriconazole.
The Annals of pharmacotherapy 2004;38(5):900-1.
2004: Elias K Manavathu; Mayur S Ramesh; Inthumathi Baskaran; Latha T Ganesan; Pranatharthi H Chandrasekar
A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
The Journal of antimicrobial chemotherapy 2004;53(2):386-9.
2004: Neeraja L Varanasi; Inthumathi Baskaran; George J Alangaden; Pranatharthi H Chandrasekar; Elias K Manavathu
Novel effect of voriconazole on conidiation of Aspergillus species.
International journal of antimicrobial agents 2004;23(1):72-9.
2003: Elias K Manavathu; George J Alangaden; Pranatharthi H Chandrasekar
Differential activity of triazoles in two-drug combinations with the echinocandin caspofungin against Aspergillus fumigatus.
The Journal of antimicrobial chemotherapy 2003;51(6):1423-5.
2003: Drew J Winston; Richard T Maziarz; Pranatharthi H Chandrasekar; Hillard M Lazarus; Mitchell Goldman; Jeffrey L Blumer; Gerhard J Leitz; Mary Territo
Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
Annals of internal medicine 2003;138(9):705-13.
2003: Drew J Winston; Andrew M Yeager; Pranatharthi H Chandrasekar; David R Snydman; Finn Bo Petersen; Mary Territo
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(6):749-58.
2002: Pranatharthi H Chandrasekar; Elias K Manavathu
Caspofungin.
Drugs of today (Barcelona, Spain : 1998) 2002;38(12):829-46.
2002: Suzanne Pulimood; Latha T Ganesan; George J Alangaden; Pranatharthi H Chandrasekar
Polymicrobial candidemia.
Diagnostic microbiology and infectious disease 2002;44(4):353-7.
2002: Rami B Ibrahim; Esteban Abella; Pranatharthi H Chandrasekar
Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantation.
The Annals of pharmacotherapy 2002;36(12):1971-2.
2002: George J Alangaden; M Wahiduzzaman; Pranatharthi H Chandrasekar
Aspergillosis: The most common community-acquired pneumonia with gram-negative Bacilli as copathogens in stem cell transplant recipients with graft-versus-host disease.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(6):659-64.
2002: Vivek Kak; Pranatharthi H Chandrasekar
Bone and joint infections in injection drug users.
Infectious disease clinics of North America 2002;16(3):681-95.
2002: Raleigh Bowden; Pranatharthi H Chandrasekar; Mary H White; Xin Li; Larry Pietrelli; Marc Gurwith; Jo-Anne H van Burik; Michel Laverdiere; Sharon Safrin; John R Wingard
A double-blind, randomized, controlled trial of amphotericin B colloidal dispersion versus amphotericin B for treatment of invasive aspergillosis in immunocompromised patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(4):359-66.
2002: Raoul Herbrecht; David W Denning; Thomas Patterson; JOHN BENNETT; Reginald E Greene; Jörg Oestmann; Winfried V Kern; Kieren Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter Troke; Ben de Pauw
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
The New England journal of medicine 2002;347(6):408-15.
2002: Ayman O Soubani; Pranatharthi H Chandrasekar
The clinical spectrum of pulmonary aspergillosis.
Chest 2002;121(6):1988-99.
2002: Mahomed-Yunus S Moosa; George J Alangaden; Elias K Manavathu; Pranatharthi H Chandrasekar
Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis.
The Journal of antimicrobial chemotherapy 2002;49(1):209-13.
2001: Pranatharthi H Chandrasekar; Jessica L Cutright; Elias K Manavathu
Aspergillus: rising frequency of clinical isolation and continued susceptibility to antifungal agents, 1994-1999.
Diagnostic microbiology and infectious disease 2001;41(4):211-4.
2001: Elias K Manavathu; Jonathan R Dimmock; Sarvesh C Vashishtha; Pranatharthi H Chandrasekar
Inhibition of H(+)-ATPase-mediated proton pumping in Cryptococcus neoformans by a novel conjugated styryl ketone.
The Journal of antimicrobial chemotherapy 2001;47(4):491-4.
2001: Elias K Manavathu; OC Abraham; Pranatharthi H Chandrasekar
Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2001;7(3):130-7.
2001: Pranatharthi H Chandrasekar; OC Abraham; J Klein; George J Alangaden; G Chalasani; L Cassells; Roger Dansey; S Abella; Chatchada Karanes; W Peters; RD Baynes
Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor cell transplantation in the outpatient setting for women with breast cancer.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(4):546-51.
2001: Pranatharthi H Chandrasekar
Empirical antifungal therapy for persistent fever in patients with neutropenia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(2):320-1.
2001: M Kanno; Pranatharthi H Chandrasekar; Gail Bentley; Richard S. Vanderheide; George J Alangaden
Disseminated cytomegalovirus disease in hosts without acquired immunodeficiency syndrome and without an organ transplant.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(2):313-6.
2000: Pranatharthi H Chandrasekar; OC Abraham; Elias K Manavathu; U Nune; K Kanuri
Effect of test medium on in vitro susceptibility testing results for Aspergillus fumigatus.
Revista iberoamericana de micología 2000;17(3):107-10.
2000: Pranatharthi H Chandrasekar; P M Arnow
Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer.
The Annals of pharmacotherapy 2000;34(9):989-95.
2000: Ananda S Prasad; James T Fitzgerald; Bin Bao; Frances W J Beck; Pranatharthi H Chandrasekar
Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate. A randomized, double-blind, placebo-controlled trial.
Annals of internal medicine 2000;133(4):245-52.
2000: Elias K Manavathu; Jessica L Cutright; David Loebenberg; Pranatharthi H Chandrasekar
A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).
The Journal of antimicrobial chemotherapy 2000;46(2):229-34.
2000: Pranatharthi H Chandrasekar; George J Alangaden; Elias K Manavathu
Aspergillus: an increasing problem in tertiary care hospitals?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(6):984-5.
2000: Pranatharthi H Chandrasekar; Jessica L Cutright; Elias K Manavathu
Efficacy of voriconazole against invasive pulmonary aspergillosis in a guinea-pig model.
The Journal of antimicrobial chemotherapy 2000;45(5):673-6.
2000: Shelly A McNeil; Nina M Clark; Pranatharthi H Chandrasekar; Carol A Kauffman
Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(2):403-4.
1999: Elias K Manavathu; Jonathan R Dimmock; Sarvesh C Vashishtha; Pranatharthi H Chandrasekar
Proton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.
Antimicrobial agents and chemotherapy 1999;43(12):2950-9.
1999: Elias K Manavathu; Jose A Vazquez; Pranatharthi H Chandrasekar
Reduced susceptibility in laboratory-selected mutants of Aspergillus fumigatus to itraconazole due to decreased intracellular accumulation of the antifungal agent.
International journal of antimicrobial agents 1999;12(3):213-9.
1999: Ananda S Prasad; Frances W J Beck; Joseph Kaplan; Pranatharthi H Chandrasekar; J Ortega; James T Fitzgerald; Paul Steven Swerdlow
Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD).
American journal of hematology 1999;61(3):194-202.
1999: Pranatharthi H Chandrasekar
Identification and treatment of herpes lesions.
Advances in wound care : the journal for prevention and healing 1999;12(5):254-62.
1999: John R Ebright; Pranatharthi H Chandrasekar; SC Marks; Marilynn R Fairfax; A Aneziokoro; M R McGinnis
Invasive sinusitis and cerebritis due to Curvularia clavata in an immunocompetent adult.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;28(3):687-9.
1999: Elias K Manavathu; Jessica L Cutright; Pranatharthi H Chandrasekar
Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents.
Journal of clinical microbiology 1999;37(3):858-61.
1999: OC Abraham; Elias K Manavathu; Jessica L Cutright; Pranatharthi H Chandrasekar
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Diagnostic microbiology and infectious disease 1999;33(1):7-11.
1998: Elias K Manavathu; Jonathan R Dimmock; Sarvesh C Vashishtha; Jessica L Cutright; Pranatharthi H Chandrasekar
In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone.
The Journal of antimicrobial chemotherapy 1998;42(5):585-90.
1998: Elias K Manavathu; Jessica L Cutright; Pranatharthi H Chandrasekar
Organism-dependent fungicidal activities of azoles.
Antimicrobial agents and chemotherapy 1998;42(11):3018-21.
1998: Elias K Manavathu; George J Alangaden; Pranatharthi H Chandrasekar
In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus.
The Journal of antimicrobial chemotherapy 1998;41(6):615-9.
1997: Tammy Lundstrom; Marilynn R Fairfax; M C Dugan; Jose A Vazquez; Pranatharthi H Chandrasekar; Esteban Abella; C Kasten-Sportes
Phialophora verrucosa infection in a BMT patient.
Bone marrow transplantation 1997;20(9):789-91.
1997: Pranatharthi H Chandrasekar; F Momin
Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team.
Bone marrow transplantation 1997;19(7):685-9.
1997: Pranatharthi H Chandrasekar; P S Nandi; Marilynn R Fairfax; Lawrence R Crane
Cutaneous infections due to Acanthamoeba in patients with acquired immunodeficiency syndrome.
Archives of internal medicine 1997;157(5):569-72.
1996: Pranatharthi H Chandrasekar
Use of vancomycin in central venous catheter-related infections.
Bone marrow transplantation 1996;17(2):299.
1996: H R Naik; Pranatharthi H Chandrasekar
Herpes simplex virus (HSV) colitis in a bone marrow transplant recipient.
Bone marrow transplantation 1996;17(2):285-6.
1995: Jose A Vazquez; T Lundstrom; Louise-Marie Dembry; Pranatharthi H Chandrasekar; Dina Boikov; M B Parri; Marcus Zervos
Invasive Candida guilliermondii infection: in vitro susceptibility studies and molecular analysis.
Bone marrow transplantation 1995;16(6):849-53.
1995: H R Naik; N Siddique; Pranatharthi H Chandrasekar
Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(6):1514-5.
1995: M P Ducharme; R L Slaughter; L H Warbasse; Pranatharthi H Chandrasekar; V Van de Velde; G Mannens; David J Edwards
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin.
Clinical pharmacology and therapeutics 1995;58(6):617-24.
1995: Pranatharthi H Chandrasekar; A Weinmann; C Shearer
Autopsy-identified infections among bone marrow transplant recipients: a clinico-pathologic study of 56 patients. Bone Marrow Transplantation Team.
Bone marrow transplantation 1995;16(5):675-81.
1995: F Momin; Pranatharthi H Chandrasekar
Antimicrobial prophylaxis in bone marrow transplantation.
Annals of internal medicine 1995;123(3):205-15.
1995: C Shearer; Pranatharthi H Chandrasekar
Pulmonary nocardiosis in a patient with a bone marrow transplant. Bone Marrow Transplantation Team.
Bone marrow transplantation 1995;15(3):479-81.
1994: George J Alangaden; Pranatharthi H Chandrasekar; E Bailey; Y Khaliq
Antifungal prophylaxis with low-dose fluconazole during bone marrow transplantation. The Bone Marrow Transplantation Team.
Bone marrow transplantation 1994;14(6):919-24.
1994: Pranatharthi H Chandrasekar; William J Brown
Clinical issues of blood cultures.
Archives of internal medicine 1994;154(8):841-9.
1994: L K Gajewski; E M Bailey; Patricia D Brown; Pranatharthi H Chandrasekar
Immune globulin use at a multihospital medical center.
American journal of hospital pharmacy 1994;51(6):801-5.
1994: Pranatharthi H Chandrasekar; C M Gatny
Effect of fluconazole prophylaxis on fever and use of amphotericin in neutropenic cancer patients. Bone Marrow Transplantation Team.
Chemotherapy 1994;40(2):136-43.
1994: Pranatharthi H Chandrasekar; C M Gatny
The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.
The Journal of antimicrobial chemotherapy 1994;33(2):309-18.
1993: John A Molinari; J A Cottone; Pranatharthi H Chandrasekar
Tuberculosis: a re-emerging healthcare challenge for the '90s.
The Journal of the Michigan Dental Association 1993;75(8):22-9, 68.
1993: Pranatharthi H Chandrasekar; J A Sluchak; James A Kruse
Therapy with cefoperazone plus sulbactam against disseminated infection due to cefoperazone-resistant Pseudomonas aeruginosa and Escherichia coli in granulocytopenic mice.
Antimicrobial agents and chemotherapy 1993;37(9):1927-30.
1993: C Shearer; Pranatharthi H Chandrasekar
Cutaneous alternariosis and regional lymphadenitis during allogeneic BMT.
Bone marrow transplantation 1993;11(6):497-9.
1993: Drew J Winston; Pranatharthi H Chandrasekar; H M Lazarus; Jesse Goodman; J L Silber; H Horowitz; R K Shadduck; C S Rosenfeld; W G Ho; M Z Islam; D N Buell
Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial.
Annals of internal medicine 1993;118(7):495-503.
1993: John A Molinari; J A Cottone; Pranatharthi H Chandrasekar
Tuberculosis in the 1990s: current implications for dentistry.
Compendium (Newtown, Pa.) 1993;14(3):276, 78, 80-82 passim.
1992: M A Touchette; Pranatharthi H Chandrasekar; M A Milad; David J Edwards
Contrasting effects of fluconazole and ketoconazole on phenytoin and testosterone disposition in man.
British journal of clinical pharmacology 1992;34(1):75-8.
1992: Jesse Goodman; D J Winston; R A Greenfield; Pranatharthi H Chandrasekar; B Fox; H Kaizer; R K Shadduck; Thomas C Shea; P Stiff; D J Friedman
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.
The New England journal of medicine 1992;326(13):845-51.
1991: A J Ahmed; James A Kruse; M T Haupt; Pranatharthi H Chandrasekar; R W Carlson
Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock.
Critical care medicine 1991;19(12):1520-5.
1991: Pranatharthi H Chandrasekar
Quinolone prophylaxis during neutropenia.
Annals of internal medicine 1991;115(10):833.
1991: E A Poplin; C J Gordon; T J Piskorowski; Pranatharthi H Chandrasekar
Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndrome.
Cancer 1991;68(1):193-4.
1991: Pranatharthi H Chandrasekar; S M Cronin
Nephrotoxicity in bone marrow transplant recipients receiving aminoglycoside plus cyclosporine or aminoglycoside alone.
The Journal of antimicrobial chemotherapy 1991;27(6):845-9.
1991: M N Bazzi; Pranatharthi H Chandrasekar
Fever and a neck mass in a young man.
Hospital practice (Office ed.) 1991;26(3):94, 99, 102.
1991: Pranatharthi H Chandrasekar; J A Sluchak
In-vitro susceptibility of cefoperazone-susceptible and -resistant gram-negative rods to cefoperazone plus sulbactam, other beta-lactams, aminoglycosides and quinolone.
Infection 1991;19(1):49-53.
1990: Pranatharthi H Chandrasekar
Intravenous immunoglobulins in gram-negative bacteremia.
Annals of internal medicine 1990;113(11):897-8.
1990: Pranatharthi H Chandrasekar; J A Molinari; James A Kruse
Risk factors for human immunodeficiency virus infection among parenteral drug abusers in a low-prevalence area.
Southern medical journal 1990;83(9):996-1001.
1990: Pranatharthi H Chandrasekar
Low-back pain and intravenous drug abusers.
Archives of internal medicine 1990;150(5):1125, 1128.
1990: Michael J Rybak; L M Albrecht; S C Boike; Pranatharthi H Chandrasekar
Nephrotoxicity of vancomycin, alone and with an aminoglycoside.
The Journal of antimicrobial chemotherapy 1990;25(4):679-87.
1990: Pranatharthi H Chandrasekar; R Cushing
Captopril and glomerulitis.
Annals of internal medicine 1990;112(7):550.
1989: Pranatharthi H Chandrasekar; J A Sluchak
Susceptibility of staphylococci to paldimycin, and emergence of resistance, in vitro.
The Journal of antimicrobial chemotherapy 1989;24(5):821-4.
1989: Pranatharthi H Chandrasekar
Nail discoloration and human immunodeficiency virus infection.
The American journal of medicine 1989;86(4):506-7.
1989: Pranatharthi H Chandrasekar; J A Sluchak
Newer agents against methicillin and/or gentamicin-resistant and -susceptible staphylococci.
Chemotherapy 1989;35(5):333-7.
1988: R L Harvey; Pranatharthi H Chandrasekar
Chronic meningitis caused by Listeria in a patient infected with human immunodeficiency virus.
The Journal of infectious diseases 1988;157(5):1091-2.
1988: S Butler; J A Molinari; R A Plezia; Pranatharthi H Chandrasekar; H Venkat
Condyloma acuminatum in the oral cavity: four cases and a review.
Reviews of infectious diseases 1988;10(3):544-50.
1988: Pranatharthi H Chandrasekar; Donald P Levine; S Price; Michael J Rybak
Comparative efficacies of imipenem-cilastatin and vancomycin in experimental aortic valve endocarditis due to methicillin resistant Staphylococcus aureus.
The Journal of antimicrobial chemotherapy 1988;21(4):461-9.
1987: Michael J Rybak; S K Bowles; Pranatharthi H Chandrasekar; David J Edwards
Increased theophylline concentrations secondary to ciprofloxacin.
Drug intelligence & clinical pharmacy 1987;21(11):879-81.
1987: Pranatharthi H Chandrasekar
"Cure" of chronic cryptosporidiosis during treatment with azidothymidine in a patient with the acquired immune deficiency syndrome.
The American journal of medicine 1987;83(1):187.
1987: Pranatharthi H Chandrasekar; J A Molinari
Corynebacterium hemolyticum bacteremia with fatal neurologic complication in an intravenous drug addict.
The American journal of medicine 1987;82(3 Spec No):638-40.
1987: Pranatharthi H Chandrasekar; Lawrence R Crane; E J Bailey
Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients.
The Journal of antimicrobial chemotherapy 1987;19(3):321-9.
1987: S V Komshian; Pranatharthi H Chandrasekar; Donald P Levine
Adenovirus pneumonia in healthy adults.
Heart & lung : the journal of critical care 1987;16(2):146-50.
1987: J L LeFrock; B R Smith; Pranatharthi H Chandrasekar; K V Rolston; A Molavi; W Kannangara
Efficacy and safety of aztreonam in the treatment of serious gram-negative bacterial infections.
Archives of internal medicine 1987;147(2):325-8.
1987: A M Pilla; Michael J Rybak; Pranatharthi H Chandrasekar
Spiramycin in the treatment of cryptosporidiosis.
Pharmacotherapy 1987;7(5):188-90.
1986: J A Hess; Pranatharthi H Chandrasekar; M Mortiere; J A Molinari
Comparative efficacy of ketoconazole and mebendazole in experimental trichinosis.
Antimicrobial agents and chemotherapy 1986;30(6):953-4.
1986: Pranatharthi H Chandrasekar; Michael J Rybak; J J Frankowski
White blood cell count and vancomycin.
The American journal of medicine 1986;81(6):1114.
1986: Pranatharthi H Chandrasekar; E Arathoon; Donald P Levine
Infections due to Achromobacter xylosoxidans. Case report and review of the literature.
Infection 1986;14(6):279-82.
1986: Pranatharthi H Chandrasekar; A P Narula
Bone and joint infections in intravenous drug abusers.
Reviews of infectious diseases 1986;8(6):904-11.
1986: Pranatharthi H Chandrasekar; James A Kruse; M F Mathews
Nosocomial infection among patients in different types of intensive care units at a city hospital.
Critical care medicine 1986;14(5):508-10.
1986: J Unowsky; Pranatharthi H Chandrasekar; W DeLorenzo; Donald P Levine
In vitro and in vivo activity of coumermycin and other antibacterial agents against methicillin-resistant strains of Staphylococcus aureus.
Chemotherapy 1986;32(6):499-505.
1985: Pranatharthi H Chandrasekar; J A Molinari
Oral candidiasis: forerunner of acquired immunodeficiency syndrome (AIDS)?
Oral surgery, oral medicine, and oral pathology 1985;60(5):532-4.
1985: L M Gutschi; Pranatharthi H Chandrasekar
Sciatic nerve damage associated with pentamidine.
Drug intelligence & clinical pharmacy 1985;19(10):762.
1985: K V Rolston; Pranatharthi H Chandrasekar; J L LeFrock
Clinical features and antimicrobial therapy of infections caused by group G streptococci.
Infection 1985;13(5):203-6.
1985: Pranatharthi H Chandrasekar; S Price; Donald P Levine
In-vitro evaluation of cefpirome (HR 810), teicoplanin and four other antimicrobials against enterococci.
The Journal of antimicrobial chemotherapy 1985;16(2):179-82.
1985: Pranatharthi H Chandrasekar; J L Lefrock
Treatment of anaerobic infections of the central nervous system.
Indian journal of pathology & microbiology 1985;28(1):7-16.
1984: J L LeFrock; A Molavi; B Smith; P Black; M Rosenberg; K Rolston; R Brodner; Pranatharthi H Chandrasekar; L Henao; D W Kannangara
Effectiveness of cefotaxime in gram-negative meningitis.
Neurosurgery 1984;15(5):679-82.
1984: Pranatharthi H Chandrasekar; K V Rolston; D W Kannangara; J L LeFrock; S A Binnick
Hot tub-associated dermatitis due to Pseudomonas aeruginosa. Case report and review of the literature.
Archives of dermatology 1984;120(10):1337-40.
1984: Pranatharthi H Chandrasekar; K V Rolston; B R Smith; J L LeFrock
Diffusion of ceftriaxone into the cerebrospinal fluid of adults.
The Journal of antimicrobial chemotherapy 1984;14(4):427-30.
1984: Pranatharthi H Chandrasekar; B R Smith; J L LeFrock; B Carr
Enterococcal superinfection and colonization with aztreonam therapy.
Antimicrobial agents and chemotherapy 1984;26(2):280-2.
1984: J L LeFrock; A Molavi; R V McCloskey; K Rolston; Pranatharthi H Chandrasekar; L Henao; B R Smith; W Kannangara; R F Schell; B B Carr
Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
The American journal of medicine 1984;77(1):72-8.
1984: K V Rolston; Pranatharthi H Chandrasekar; J L LeFrock
Antimicrobial tolerance in group C and group G streptococci.
The Journal of antimicrobial chemotherapy 1984;13(4):389-92.
1984: V Chokkavelu; Pranatharthi H Chandrasekar; K Rolston; J L LeFrock; R F Schell
Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
Chemotherapy 1984;30(2):97-101.
1984: Pranatharthi H Chandrasekar; K V Rolston; V Chokkavelu; J L Le Frock; D W Kannangara
Comparative efficacy of four antibiotics in anaerobic pulmonary infection. An experimental model in rabbits.
Chemotherapy 1984;30(5):331-6.
1984: Pranatharthi H Chandrasekar; R F Schell; J L LeFrock; K V Rolston; M Francisco
Activity of cefsulodin, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Chemotherapy 1984;30(3):165-9.
1984: K V Rolston; Pranatharthi H Chandrasekar; J L LeFrock; R F Schell
The activity of ceftazidime, other beta-lactams, and aminoglycosides against Pseudomonas aeruginosa.
Chemotherapy 1984;30(1):31-4.
1983: K V Rolston; Pranatharthi H Chandrasekar; B R Smith; J L LeFrock
The penetration of cefmenoxime into cerebrospinal fluid across non-inflamed meninges.
The Journal of antimicrobial chemotherapy 1983;12(5):519-21.
1983: J L LeFrock; A Molavi; K Rolston; B Smith; R Schell; Pranatharthi H Chandrasekar; B Carr
In-vitro and in-vivo comparison of mezlocillin and cefoxitin.
The Journal of antimicrobial chemotherapy 1983;11 Suppl C():83-90.
1982: J L LeFrock; A Molavi; A L Lentnek; K V Rolston; Pranatharthi H Chandrasekar; B R Smith; W Kannangara; R F Schell; S S Oaks; B B Carr
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
The Journal of antimicrobial chemotherapy 1982;10 Suppl C():215-21.